News

100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
Applied Clinical Trials Online5h
FDA Supports Continued Development of Eftilagimod Alfa in PD-L1–Negative Head and Neck Cancer
Following positive Phase IIb TACTI-003 data, the FDA has endorsed further evaluation of Immutep’s efti-Keytruda combination in first-line recurrent/metastatic HNSCC patients with PD-L1 CPS <1, a ...
Targeted Oncology12h
Eftilagimod Alfa Demonstrates Potential in PD-L1–Low Head and Neck Cancer
Eftilagimod alfa shows promise as a novel immunotherapy for head and neck cancer patients with low PD-L1 expression, offering ...
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions
Former FDA Director David Feigal joins Keyron as Head of Regulatory Affairs Dr Joyce Peetermans (ex-Boston Scientific) joins as Acting CTO Christopher Rowland (ex-Boston Scientific) ...
The Mercury6h
The Voting Rights Act is turning 60. Civil rights marchers recall a hard-won struggle
Wednesday marks the 60th anniversary of the landmark legislation becoming law. Those at the epicenter of the fight for voting ...
Opinion
The New Republic on MSN14dOpinion
RFK Jr. Is Letting AI Help Run the FDA. There’s Just One Problem
Hallucinations are a known problem with generative AI models—and Elsa is no different, according to Jeremy Walsh, the head of AI at the FDA. “Elsa is no different from lots of [large language models] ...
ABC News15d
FDA head warns of illegal vaping products from China
An influx of illegal vapes that are appealing to children has been making its way into the U.S. from China, the head of the FDA warned in an interview with ABC News.
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
Oral, non-opioid drug candidate advancing through Phase 1 and nearing completion of the single ascending dose (SAD) portion ...
Medscape7d
FDA Seeks Schedule I Status for ‘Legal Morphine’
The FDA says synthetic, concentrated 7-hydroxymitragyine, a potent metabolite of kratom, is an opioid and should be ...
Jefferson Public Radio12d
Warning labels on menopause treatments 'scare women,' doctors tell the FDA
The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...
The Manila Times8d
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft ...
Calidi Biotherapeutics, Inc. ('Calidi” or the 'Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver ...
News-Medical.Net23h
Health Implications of p‑Phenylenediamine: The Aromatic Amine in Permanent Hair Dye
Uncover the risks and realities of a key hair dye ingredient as science, safety, and regulation collide in the quest for ...